AMAG Pharmaceuticals to buy biopharmaceutical firm Perosphere

______________________________________________________________________________________________

The deal will allow AMAG to acquire global rights of ciraparantag, a next generation anticoagulant reversal agent, from Perosphere. As per terms of the deal, Perosphere equityholders will

The post AMAG Pharmaceuticals to buy biopharmaceutical firm Perosphere appeared first on Pharmaceutical Business review.